Maintelyte (Magnesium Chloride Hexahydrate, Potassium Chloride, Sodium Chloride, Glucose, Sodium Acetate Trihydr)

The formulation supplies key ions—magnesium, potassium, sodium and acetate—directly into the bloodstream, restoring electrolyte balance, supporting cardiac and neuromuscular function, and contributing to acid‑base regulation. Glucose provides an immediate energy source and helps maintain osmotic pressure.

The dose of Maintelyte is determined by the prescribing clinician based on the patient’s fluid status, electrolyte levels, body weight and clinical condition. No fixed regimen is provided here; the prescriber sets the appropriate volume and rate.

Safety of intravenous electrolyte solutions like Maintelyte during pregnancy or lactation depends on the clinical need and maternal‑fetal monitoring. The decision should be made by a qualified healthcare professional who can weigh potential benefits against any risks.

To order Maintelyte, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements) and necessary import documentation.

Maintelyte differs from standard crystalloid solutions by containing a broader mix of electrolytes, acetate and glucose, which can address both fluid volume deficits and specific electrolyte deficiencies in one infusion. Other fluids may lack magnesium or acetate, requiring additional supplements for comprehensive correction.

Maintelyte should be stored at 2‑8 °C, kept refrigerated, protected from light, and must not be frozen or shaken vigorously. Follow the label instructions and ensure the container remains sealed until use to maintain sterility and solution stability.

Maintelyte is administered intravenously by a qualified healthcare professional. The solution is infused through a sterile IV line, with the rate adjusted according to the patient’s fluid needs, electrolyte status and clinical response, typically under continuous monitoring.

Serious risks include severe hyperkalemia or hypermagnesemia, which can cause cardiac arrhythmias or respiratory depression, as well as anaphylactic reactions and catheter‑related infections. Prompt monitoring of electrolyte levels and patient vitals helps mitigate these hazards.

Patients with known hypersensitivity to any component, severe renal failure where electrolyte excretion is compromised, or those with uncontrolled hyperkalemia or hypermagnesemia should not receive Maintelyte. Clinical judgment is essential to identify contraindications.